High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial
- PMID: 36889914
- PMCID: PMC10555488
- DOI: 10.1136/sextrans-2022-055696
High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial
Abstract
Introduction: We investigated the prevalence, incidence and factors associated with sexually transmitted infections (STIs) among young African women seeking HIV pre-exposure prophylaxis (PrEP).
Methods: HPTN 082 was a prospective, open-label PrEP study enrolling HIV-negative sexually active women aged 16-25 years in Cape Town and Johannesburg, South Africa, and Harare, Zimbabwe. Endocervical swabs from enrolment, months 6 and 12 were tested for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) by nucleic acid amplification, and Trichomonas vaginalis (TV) by a rapid test. Intracellular tenofovir-diphosphate (TFV-DP) concentrations in dried blood spots were measured at months 6 and 12. Associations between risk characteristics and STI outcomes were assessed using Poisson regression.
Results: Of 451 enrolled participants, 55% had an STI detected at least once. CT incidence was 27.8 per 100 person-years (py) (95% CI 23.1, 33.2), GC incidence was 11.4 per 100 py (95% CI 8.5, 15.0) and TV incidence was 6.7 per 100 py (95% CI 4.5, 9.5). 66% of incident infections were diagnosed in women uninfected at baseline. Baseline cervical infection (GC or CT) risk was highest in Cape Town (relative risk (RR) 2.38, 95% CI 1.35, 4.19) and in those not living with family (RR 1.87, 95% 1.13, 3.08); condom use was protective (RR 0.67, 95% CI 0.45, 0.99). Incident CT was associated with baseline CT (RR 2.01; 95% CI 1.28, 3.15) and increasing depression score (RR 1.05; 95% CI 1.01, 1.09). Incident GC was higher in Cape Town (RR 2.40; 95% CI 1.18, 4.90) and in participants with high PrEP adherence (TFV-DP concentrations ≥700 fmol/punch) (RR 2.04 95% CI 1.02, 4.08).
Conclusion: Adolescent girls and young women seeking PrEP have a high prevalence and incidence of curable STIs. Alternatives to syndromic management for diagnosis and treatment are needed to reduce the burden of STIs in this population.
Trial registration number: NCT02732730.
Keywords: AFRICA; Chlamydia Infections; Gonorrhea; Pre-Exposure Prophylaxis.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.Lancet HIV. 2022 Oct;9(10):e680-e689. doi: 10.1016/S2352-3018(22)00195-3. Epub 2022 Sep 7. Lancet HIV. 2022. PMID: 36087612 Free PMC article. Clinical Trial.
-
PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.PLoS Med. 2021 Jun 18;18(6):e1003670. doi: 10.1371/journal.pmed.1003670. eCollection 2021 Jun. PLoS Med. 2021. PMID: 34143779 Free PMC article. Clinical Trial.
-
Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial.Sex Transm Infect. 2024 Feb 19;100(2):77-83. doi: 10.1136/sextrans-2023-055975. Sex Transm Infect. 2024. PMID: 38124133 Free PMC article. Clinical Trial.
-
Structural and community-level interventions for increasing condom use to prevent the transmission of HIV and other sexually transmitted infections.Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD003363. doi: 10.1002/14651858.CD003363.pub3. Cochrane Database Syst Rev. 2014. PMID: 25072817 Free PMC article. Review.
-
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. Cochrane Database Syst Rev. 2011. PMID: 21412869 Review.
Cited by
-
Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT).BMJ Open. 2024 May 1;14(5):e084918. doi: 10.1136/bmjopen-2024-084918. BMJ Open. 2024. PMID: 38692732 Free PMC article.
-
Realising agency: insights from participatory research with learners in a South African sexual and reproductive health programme.Front Public Health. 2024 Oct 9;12:1329425. doi: 10.3389/fpubh.2024.1329425. eCollection 2024. Front Public Health. 2024. PMID: 39450389 Free PMC article.
-
High STI burden among a cohort of adolescents aged 12-19 years in a youth-friendly clinic in South Africa.PLoS One. 2024 Jul 10;19(7):e0306771. doi: 10.1371/journal.pone.0306771. eCollection 2024. PLoS One. 2024. PMID: 38985722 Free PMC article.
-
Prevalence of sexually transmitted infections (STIs), associations with sociodemographic and behavioural factors, and assessment of the syndromic management of vaginal discharge in women with urogenital complaints in Mozambique.Front Reprod Health. 2024 Apr 18;6:1323926. doi: 10.3389/frph.2024.1323926. eCollection 2024. Front Reprod Health. 2024. PMID: 38706519 Free PMC article.
-
Awareness of Heightened Sexual and Behavioral Vulnerability as a Trigger for PrEP Resumption Among Adolescent Girls and Young Women in East and Southern Africa.Curr HIV/AIDS Rep. 2023 Dec;20(6):333-344. doi: 10.1007/s11904-023-00680-y. Epub 2023 Dec 5. Curr HIV/AIDS Rep. 2023. PMID: 38051383 Free PMC article. Review.
References
-
- UNAIDS . The gap report. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS, 2014: 24–6.
-
- Ness RB, Soper DE, Holley RL, et al. . Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health (peach) randomized trial. Am J Obstet Gynecol 2002;186:929–37. 10.1067/mob.2002.121625 - DOI - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous